CONTINUE TO SITE
OR WAIT 15 SECS
German firm Boehringer Ingelheim has licensed a pre-clinical programme from Japan's Kyowa Kirin to develop a p
Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing,
Australia-based AI-enabled pharmaceutical company Algorae Pharmaceuticals has entered into a binding term shee
Nanjing IASO Biotechnology has signed an agreement with Korea's GC Cell to introduce the CAR-T therapy "Fucaso
AusBiotech, Australia’s peak industry body representing more than 3,000 life sciences members, has forma
A new collaboration between Texas Medical Center, the world’s largest innovation hub, and the Osong Medi
Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrati
South Korea's Samsung C&T (SCT), Samsung Electronics (SEC), and US-based GRAIL, Inc. have signed a binding
Australia’s first and only clinical and commercial-scale viral vector Contract Development and Manufactu
South Korea-based SK pharmteco and LOTTE BIOLOGICS have signed a Letter of Intent (LOI) for a strategic collab
How Private Sector is Fueling APAC Vax Demand
As vaccine debates resurface in global politics, most recently fuelled by renewed anti-vaccine rhetoric from the US President Donald Trump, attention is once again turning to the critical role vaccines play in safeguarding public health. Across the Asia-Pacific region, vaccines are evolving from a purely public health tool into a broader healthcare priority with growing private sector participation. Private-sector vaccine sales now account for an estimated 15–35 per cent of total revenue. According to Frost & Sullivan, private-market shares vary widely from around 20 per cent in China and 25–30 per cent in India to as high as 35–40 per cent in parts of Southeast Asia. Strengthened by post-pandemic health awareness, expanding middle-class purchasing power, and new manufacturer strategies, Asia’s private vaccine market is becoming an increasingly important force shaping growth, innovation, and access across the region.
For Feedback, please email us at: communications@mmactiv.com
Dubai International Pharmaceutical & Technology Conference& Exhibition (DUPHAT)
Index Conferences & Exhibitions
info@duphat.ae https://duphat.ae/Dubai World Trade Center
AAPS PharmaSci 360 2025
AAPS
aaps@aaps.org https://www.aaps.org/pharmsci/future-annual-eventsSan Antonio
